Research supports the need for a 3rd mRNA COVID vaccine in patients taking immunosuppressants - News-Medical.Net
New research posted to the medRxiv* preprint server finds patients with immune-mediated inflammatory diseases undergoing anti-TNF therapy had the greatest reduction of antibody levels three months after vaccination. In addition, they had weaker neutralization…
New research posted to the medRxiv* preprint server finds patients with immune-mediated inflammatory diseases undergoing anti-TNF therapy had the greatest reduction of antibody levels three months af… [+6226 chars]
Read More
Other Stories in Health
- Stem-cell implants restore vision in patients with corneal stem cell deficiency
- Reducing In-Home Smoking: Practical Approaches for Primary Care Clinicians
- Johns Hopkins University MSN (Entry into Nursing) Spring 2025
- 7 benefits of eating a rainbow diet
- Study shows toddlers learn better from impossible events
- New model sheds light on APOE4's role in Alzheimer's pathology
- How calcium and magnesium deficiencies impact cognitive health
- Lincoln Memorial University CRNA 2025
- Heard of the 'UTI vaccine'? What you need to know about how it treats recurrent infections
.png)
